284 related articles for article (PubMed ID: 1356625)
1. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
2. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
[TBL] [Abstract][Full Text] [Related]
3. Evidence for genetic heterogeneity in familial Wilms' tumor.
Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton MR; Narod SA
Nat Genet; 1996 Aug; 13(4):461-3. PubMed ID: 8696342
[TBL] [Abstract][Full Text] [Related]
5. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
[TBL] [Abstract][Full Text] [Related]
6. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
8. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
[TBL] [Abstract][Full Text] [Related]
9. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
10. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
Mason JE; Goodfellow PJ; Grundy PE; Skinner MA
J Pediatr Surg; 2000 Jun; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
[TBL] [Abstract][Full Text] [Related]
11. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
13. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
14. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
15. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
17. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
18. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
20. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
